| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0e688bf5dcaf406ff0e4eb7bf99ba05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441f7c6829d19d1f693aa6ad677f2e8d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede18bc03535092eef074e2c4f13446b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52540175d90e89ae5e97979febda5bcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8aa4d94a5ba7bd10fefa780e56b42e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d553bf50999ef357954ac33328344654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7fc7678d2f81783646f186a062f43b9 |
| publicationDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180123360-A |
| titleOfInvention |
Novel Biomarkers for Predicting Susceptibility to Anti-Cancer Drug and Uses Thereof |
| abstract |
The present invention relates to a biomarker for predicting susceptibility to an anticancer agent and a use thereof, and more particularly, to a biomarker for predicting susceptibility to an anticancer agent including a mutant of MAP3K10 (Mitogen-Activated Protein Kinase Kinase Kinase 10) A kit for predicting susceptibility to an anticancer agent comprising the agent for detecting a mutation of a MAP3K10 gene, a kit for predicting susceptibility to an anticancer agent comprising the composition, And an information providing method for predicting susceptibility to anticancer drugs. INDUSTRIAL APPLICABILITY According to the present invention, since the antimicrobial susceptibility prediction and prediction effect are excellent, the present invention can be usefully used for cancer treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113684276-A |
| priorityDate |
2017-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |